Hep B-vaccinol, created in 2001 (Germany), from 316 sister brands and 4958 competing brands. Hep B-vaccinol is a brand of STADA ARZNEIMITTEL, listed on the stock exchange of Etats-Unis. The International Securities Identification Number (ISIN) of STADA ARZNEIMITTEL is DE0007251803. Hep B-vaccinol belongs to the Drug Manufacturers business sector.